PT717041E - Hidratos de paclitaxel cristalinos - Google Patents

Hidratos de paclitaxel cristalinos

Info

Publication number
PT717041E
PT717041E PT95119595T PT95119595T PT717041E PT 717041 E PT717041 E PT 717041E PT 95119595 T PT95119595 T PT 95119595T PT 95119595 T PT95119595 T PT 95119595T PT 717041 E PT717041 E PT 717041E
Authority
PT
Portugal
Prior art keywords
hydrates
crystalline paclitaxel
paclitaxel
pseudopolymorph
crystalline
Prior art date
Application number
PT95119595T
Other languages
English (en)
Inventor
Robert Kevin Perrone
Scott R Stenberg
Sheeram Agharkar
Murray A Kaplan
Akram Saab
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23396320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT717041(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT717041E publication Critical patent/PT717041E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
PT95119595T 1994-12-13 1995-12-12 Hidratos de paclitaxel cristalinos PT717041E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35512594A 1994-12-13 1994-12-13

Publications (1)

Publication Number Publication Date
PT717041E true PT717041E (pt) 2002-11-29

Family

ID=23396320

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95119595T PT717041E (pt) 1994-12-13 1995-12-12 Hidratos de paclitaxel cristalinos

Country Status (9)

Country Link
EP (1) EP0717041B2 (pt)
JP (1) JPH08208636A (pt)
AT (1) ATE221879T1 (pt)
AU (1) AU699542B2 (pt)
CA (1) CA2163837C (pt)
DE (1) DE69527696T3 (pt)
DK (1) DK0717041T3 (pt)
ES (1) ES2181744T5 (pt)
PT (1) PT717041E (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
FR2729666A1 (fr) * 1995-01-25 1996-07-26 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
ES2226120T3 (es) † 1997-03-31 2005-03-16 Boston Scientific Limited Inhibidor terapeutico de celulas del musculo liso vascular.
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
PL203300B1 (pl) * 2000-10-31 2009-09-30 Akad Medyczna Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
WO2003047508A2 (en) 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Paclitaxel solvates
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US7919108B2 (en) 2006-03-10 2011-04-05 Cook Incorporated Taxane coatings for implantable medical devices
US7875284B2 (en) 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
WO2008005284A2 (en) * 2006-06-30 2008-01-10 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
NZ588816A (en) 2007-01-21 2011-11-25 Hemoteq Ag Medical device for the treatment of stenoses of corporal lumina and for the prevention of impending restenoses
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
WO2011005421A2 (en) 2009-07-10 2011-01-13 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
JP5933434B2 (ja) 2009-07-17 2016-06-08 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 薬剤送達バルーンの製造方法
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (en) 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
CN106170307B (zh) * 2014-02-14 2020-07-28 波士顿科学国际有限公司 具有治疗剂释放的快速降解栓塞颗粒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) † 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) † 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5380916A (en) † 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
TW467896B (en) † 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes

Also Published As

Publication number Publication date
ES2181744T3 (es) 2003-03-01
ATE221879T1 (de) 2002-08-15
DE69527696T3 (de) 2008-04-03
EP0717041B1 (en) 2002-08-07
DE69527696D1 (de) 2002-09-12
EP0717041B2 (en) 2007-08-15
CA2163837A1 (en) 1996-06-14
DK0717041T3 (da) 2002-11-25
DE69527696T2 (de) 2003-04-03
AU4035595A (en) 1996-06-20
AU699542B2 (en) 1998-12-03
CA2163837C (en) 1999-07-20
EP0717041A1 (en) 1996-06-19
ES2181744T5 (es) 2008-03-01
JPH08208636A (ja) 1996-08-13

Similar Documents

Publication Publication Date Title
PT717041E (pt) Hidratos de paclitaxel cristalinos
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
ZA200007222B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same.
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
CA2152771A1 (en) 7-o-ethers of taxane derivatives
SE9801494D0 (sv) Novel use
DE69936052D1 (de) N1 modifizierte glycopeptide
FI945439A0 (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät koostumukset
DE60029084D1 (de) Neue depsipeptid-verbindung
DE69513889T2 (de) Degradierbare Mischungszusammensetzung
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
BR9902081A (pt) Combinação de dofetilida e um bloqueador dos canais de cálcio
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents